News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-21 12:0:6 pm Alvotech (ALVO) Q4 2023 Earnings Call Transcript SeekingAlpha
2024-03-20 1:15:0 pm Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update GlobeNewswire
2024-03-05 1:1:0 pm Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET GlobeNewswire
2024-02-29 1:5:0 pm Alvotech Appoints Interim Chief Quality Officer GlobeNewswire
2024-02-26 1:25:0 am Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share GlobeNewswire
2024-02-23 5:15:0 pm Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira® Business Wire
2024-02-15 3:30:0 am Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab) GlobeNewswire
2024-02-04 5:38:0 am Is Alvotech (NASDAQ:ALVO) Trading At A 48% Discount? Simply Wall St.
2024-01-29 1:0:0 am Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva® GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information